Mesalamine 800mg DRTablet
Gastrointestinal

Mesalamine 800mg DR

Mesalamine

High-strength delayed-release mesalamine tablet for reduced pill burden in ulcerative colitis management. Manufactured by Sun Pharma and Cipla for gastroenterology export.

Strengths

800mg

Packing

30 tablets/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Mesalamine 800mg (delayed release)
Dosage Form
Tablet
Available Strengths
800mg
Packing
30 tablets/bottle
Route of Administration
Oral
Dosage
Induction: 2.4-4.8g/day in divided doses for 6 weeks; Maintenance: 1.6g/day
Indications
Ulcerative colitis (induction and maintenance), Crohn's colitis, proctitis
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C, protect from moisture
Shelf Life
24 months
Side Effects
Headache, nausea, abdominal pain, diarrhea, flatulence, nephrotoxicity (rare)
Precautions
Monitor renal function; salicylate hypersensitivity; swallow whole; paradoxical worsening possible; not interchangeable with other mesalamine formulations

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Mesalamine 800mg DR?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote